Ladenburg Thalmann Financial Services’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio SEEL Stock Details SEEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$3K	Hold	1	–	–	﹤0.01%	4995
2019 Q3	$2K	Hold	1	–	–	﹤0.01%	5021
2019 Q2	$5K	Buy	+1	New	+$10.5K	﹤0.01%	4733
2019 Q1	–	Hold	0	–	–	–	5373
2018 Q4	–	Hold	0	–	–	–	5369
2018 Q3	–	Hold	0	–	–	–	5056
2018 Q2	–	Hold	0	–	–	–	5031
2018 Q1	–	Hold	0	–	–	–	5031
2017 Q4	–	Hold	0	–	–	–	5141
2017 Q3	–	Hold	0	–	–	–	5042
2017 Q2	–	Hold	0	–	–	–	4991
2017 Q1	–	Hold	0	–	–	–	4991
2016 Q4	–	Hold	0	–	–	–	4971
2016 Q3	–	Hold	0	–	–	–	4891
2016 Q2	–	Hold	0	–	–	–	4860
2016 Q1	–	Hold	0	–	–	–	4829
2015 Q4	–	Hold	0	–	–	–	4808
2015 Q3	–	Hold	0	–	–	–	4472
2015 Q2	–	Hold	0	–	–	–	4543
2015 Q1	–	Hold	0	–	–	–	4464
2014 Q4	–	Hold	0	–	–	–	4453

Other funds holding SEEL

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UIC

Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

MWP

MYCIO Wealth Partners Philadelphia, Pennsylvania $502M AUM 11.65% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Ladenburg Thalmann Financial Services's SEEL Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its Seelos Therapeutics, Inc. Common Stock (SEEL) position steady in Q4 2019 at 1 share worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #4995.

Ladenburg Thalmann Financial Services first reported a position in SEEL in Q2 2019 and has held it in 3 quarters since. The position peaked at $5K in Q2 2019. 13 funds tracked by Wall St. Rank hold SEEL as of Q4 2019.

Ladenburg Thalmann Financial Services held 1 share of Seelos Therapeutics, Inc. Common Stock worth $3K as of Q4 2019.
Ladenburg Thalmann Financial Services left its Seelos Therapeutics, Inc. Common Stock share count unchanged in Q4 2019.
Seelos Therapeutics, Inc. Common Stock made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4995 holding.
Ladenburg Thalmann Financial Services first reported a position in Seelos Therapeutics, Inc. Common Stock in Q2 2019 and has held it in 3 quarters since.
Ladenburg Thalmann Financial Services's Seelos Therapeutics, Inc. Common Stock position peaked at $5K in Q2 2019.
13 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.